Clinical Trial Update: Study to Compare the Safety and Efficacy of UB-851 and Eprex® [Phase 3]

View source ↗

Summary

Phase 3 study comparing UB-851 to Eprex in renal anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Anemia

Drugs mentioned

• Eprex (epoetin alfa)
• UB-851

Snippet

Sponsor: UBI Pharma Inc. | Conditions: Renal Anemia | Phase 3 | Status: COMPLETED